These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2861888

  • 1. Prediction of treatment response in schizophrenia: clinical use of neuroleptic blood levels.
    Tang SW.
    Can J Psychiatry; 1985 Jun; 30(4):249-50. PubMed ID: 2861888
    [Abstract] [Full Text] [Related]

  • 2. The Nithsdale schizophrenia surveys. IX: Akathisia, parkinsonism, tardive dyskinesia and plasma neuroleptic levels.
    McCreadie RG, Robertson LJ, Wiles DH.
    Br J Psychiatry; 1992 Jun; 160():793-9. PubMed ID: 1352165
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
    Chouinard G, Annable L, Jones BD, Collu R.
    Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lack of relationship of neuroleptic dose and blood serum levels to neuropsychological performance on the LNNB in chronic schizophrenia.
    Puente AE, Tune L.
    Int J Neurosci; 1996 Oct; 87(1-2):107-10. PubMed ID: 8913825
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Problems in classification of schizophrenics as neuroleptic responders and nonresponders.
    Csernansky JG, Kaplan J, Hollister LE.
    J Nerv Ment Dis; 1985 Jun; 173(6):325-31. PubMed ID: 2860202
    [Abstract] [Full Text] [Related]

  • 15. The pharmacoepidemiology of treatment-refractory schizophrenia.
    Collins EJ, Hogan TP, Awad AG.
    Can J Psychiatry; 1992 Apr; 37(3):192-5. PubMed ID: 1350502
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Blood biogenic amines during clozapine treatment of early-onset schizophrenia.
    Schulz E, Fleischhaker C, Clement HW, Remschmidt H.
    J Neural Transm (Vienna); 1997 Apr; 104(10):1077-89. PubMed ID: 9503259
    [Abstract] [Full Text] [Related]

  • 19. Effects of neuroleptic treatment on cortisol and 3-methoxy-4-hydroxyphenylethyl glycol levels in blood.
    Wik G.
    J Endocrinol; 1995 Mar; 144(3):425-9. PubMed ID: 7738466
    [Abstract] [Full Text] [Related]

  • 20. Radioreceptor assay of neuroleptics in refractory chronic schizophrenic patients.
    Lindenmayer JP, Smith D, Katz I.
    J Clin Psychiatry; 1984 Mar; 45(3):117-9. PubMed ID: 6142035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.